MKI67 and prostate carcinoma: The number of Ki67-positive cells was markedly reduced in the tumors derived from ARF1 knockdown cells as compared with the tumors derived from the control cells (Figure 4C and 4D), indicating that ARF1 affects prostate cancer cell proliferation in vivo.